title: Apomorphine in malignant syndrome due to levodopa withdrawal.
abstract: We report a case of neuroleptic malignant syndrome (NMS) following abrupt reduction of chronic levodopa treatment in a 71 year old female parkinsonian patient. The NMS resolved within 24 hours of the addition of apomorphine to levodopa therapy.
authors.affiliation: Clinica Neurologica, Università di Pisa.
authors.forename: U
authors.initials: U
authors.lastname: Bonuccelli
authors.forename: P
authors.initials: P
authors.lastname: Piccini
authors.forename: G U
authors.initials: GU
authors.lastname: Corsini
authors.forename: A
authors.initials: A
authors.lastname: Muratorio
mesh_terms: D000368:Aged; D001058:Apomorphine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy*; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*
chemical_list: D007980:Levodopa; D001058:Apomorphine